Michelle D. James

2.1k total citations · 1 hit paper
9 papers, 870 citations indexed

About

Michelle D. James is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Michelle D. James has authored 9 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Economics and Econometrics. Recurrent topics in Michelle D. James's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (4 papers) and Economic and Environmental Valuation (3 papers). Michelle D. James is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (4 papers) and Economic and Environmental Valuation (3 papers). Michelle D. James collaborates with scholars based in United Kingdom, United States and Germany. Michelle D. James's co-authors include Trudy Ann Cameron, Veronica G. Thomas, Bharat Jasani, Richard Adams, Tim Maughan, Angela Meade, Jeremy P. Cheadle, David J. Fisher, Richard Kaplan and Shelley Idziaszczyk and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Marketing Research and Clinical Cancer Research.

In The Last Decade

Michelle D. James

9 papers receiving 749 citations

Hit Papers

Efficient Estimation Methods for "Closed-Ended" Contingen... 1987 2026 2000 2013 1987 100 200 300 400

Peers

Michelle D. James
Grant D. Jacobsen United States
Richard O. Zerbe United States
Chris Koski United States
Therese Grijalva United States
Anthony Murphy United States
Grant D. Jacobsen United States
Michelle D. James
Citations per year, relative to Michelle D. James Michelle D. James (= 1×) peers Grant D. Jacobsen

Countries citing papers authored by Michelle D. James

Since Specialization
Citations

This map shows the geographic impact of Michelle D. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle D. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle D. James more than expected).

Fields of papers citing papers by Michelle D. James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle D. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle D. James. The network helps show where Michelle D. James may publish in the future.

Co-authorship network of co-authors of Michelle D. James

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle D. James. A scholar is included among the top collaborators of Michelle D. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle D. James. Michelle D. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Richman, Susan D., Richard Adams, Philip Quirke, et al.. (2015). Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial. Journal of Clinical Pathology. 69(1). 35–41. 16 indexed citations
2.
Smith, Christopher G., David J. Fisher, Bart Claes, et al.. (2013). Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab. Clinical Cancer Research. 19(15). 4104–4113. 86 indexed citations
3.
Adams, Richard, David J. Fisher, Susan Farragher, et al.. (2012). Epiregulin (EREG) and amphiregulin (AREG) gene expression to predict response to cetuximab therapy in combination with oxaliplatin (Ox) and 5FU in first-line treatment of advanced colorectal cancer (aCRC).. Journal of Clinical Oncology. 30(15_suppl). 3516–3516. 5 indexed citations
4.
5.
Adams, Richard, Michelle D. James, Christopher G. Smith, et al.. (2011). Epidermal growth factor receptor (EGFR) as a predictive and prognostic marker in patients with advanced colorectal cancer (aCRC): The MRC COIN trial experience.. Journal of Clinical Oncology. 29(4_suppl). 359–359. 4 indexed citations
6.
Thomas, Veronica G. & Michelle D. James. (1988). Body image, dieting tendencies, and sex role traits in urban black women. Sex Roles. 18(9-10). 523–529. 56 indexed citations
7.
Cameron, Trudy Ann & Michelle D. James. (1987). Estimating Willingness to Pay from Survey Data: An Alternative Pre-Test-Market Evaluation Procedure. Journal of Marketing Research. 24(4). 389–389. 55 indexed citations
8.
Cameron, Trudy Ann & Michelle D. James. (1987). Estimating Willingness to Pay from Survey Data: An Alternative Pre-Test-Market Evaluation Procedure. Journal of Marketing Research. 24(4). 389–395. 157 indexed citations
9.
Cameron, Trudy Ann & Michelle D. James. (1987). Efficient Estimation Methods for "Closed-Ended" Contingent Valuation Surveys. The Review of Economics and Statistics. 69(2). 269–269. 473 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026